106 related articles for article (PubMed ID: 9098405)
1. Genomic MHC haplotyping of mutant cell lines using a novel marker.
Degli-Esposti MA; Williamson JF; Tay GK; Salmon B; Joseph GA; Morley AA; Dawkins RL
Eur J Immunogenet; 1993 Oct; 20(5):373-80. PubMed ID: 9098405
[TBL] [Abstract][Full Text] [Related]
2. Novel detection of restriction fragment length polymorphisms in the human major histocompatibility complex.
Cross SJ; Tonks S; Trowsdale J; Campbell RD
Immunogenetics; 1991; 34(6):376-84. PubMed ID: 1684176
[TBL] [Abstract][Full Text] [Related]
3. Genomic organization of a polymorphic duplicated region centromeric of HLA-B.
Leelayuwat C; Abraham LJ; Tabarias H; Christiansen FT; Dawkins RL
Immunogenetics; 1992; 36(4):208-12. PubMed ID: 1353477
[TBL] [Abstract][Full Text] [Related]
4. Sequence differences between HLA-B and TNF distinguish different MHC ancestral haplotypes.
Abraham LJ; Leelayuwat C; Grimsley G; Degli-Esposti MA; Mann A; Zhang WJ; Christiansen FT; Dawkins RL
Tissue Antigens; 1992 Mar; 39(3):117-21. PubMed ID: 1350870
[TBL] [Abstract][Full Text] [Related]
5. Conserved extended haplotypes of the major histocompatibility complex: further characterization.
Dorak MT; Shao W; Machulla HK; Lobashevsky ES; Tang J; Park MH; Kaslow RA
Genes Immun; 2006 Sep; 7(6):450-67. PubMed ID: 16791278
[TBL] [Abstract][Full Text] [Related]
6. Ancestral haplotypes carry haplotypic and haplospecific polymorphisms of BAT1: possible relevance to autoimmune disease.
Degli-Esposti MA; Leelayuwat C; Dawkins RL
Eur J Immunogenet; 1992 Jun; 19(3):121-7. PubMed ID: 1352699
[TBL] [Abstract][Full Text] [Related]
7. MHC-extended haplotypes in families of patients with Graves' disease.
Ratanachaiyavong S; Lloyd L; Darke C; McGregor AM
Hum Immunol; 1993 Feb; 36(2):99-111. PubMed ID: 8096501
[TBL] [Abstract][Full Text] [Related]
8. Low degree of DNA polymorphism in the HLA-linked lymphotoxin (tumour necrosis factor beta) gene.
Partanen J; Koskimies S
Scand J Immunol; 1988 Sep; 28(3):313-6. PubMed ID: 2904171
[TBL] [Abstract][Full Text] [Related]
9. A physical map including a new class I gene (cda12) of the human major histocompatibility complex (A2/B13 haplotype) derived from a monosomy 6 mutant cell line.
Ragoussis J; Bloemer K; Pohla H; Messer G; Weiss EH; Ziegler A
Genomics; 1989 Apr; 4(3):301-8. PubMed ID: 2497062
[TBL] [Abstract][Full Text] [Related]
10. Association of four HLA class III region genomic markers with HLA haplotypes.
Pei J; Choo SY; Spies T; Strominger JL; Hansen JA
Tissue Antigens; 1991 May; 37(5):191-6. PubMed ID: 1685263
[TBL] [Abstract][Full Text] [Related]
11. Extensive genetic polymorphism in the human tumor necrosis factor region and relation to extended HLA haplotypes.
Jongeneel CV; Briant L; Udalova IA; Sevin A; Nedospasov SA; Cambon-Thomsen A
Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9717-21. PubMed ID: 1946393
[TBL] [Abstract][Full Text] [Related]
12. Association of polymorphisms in the HLA-B region with extended haplotypes.
Egea GE; Yunis I; Spies T; Strominger J; Awdeh ZL; Alper CA; Yunis EJ
Immunogenetics; 1991; 33(1):4-11. PubMed ID: 1671666
[TBL] [Abstract][Full Text] [Related]
13. MHC class III polymorphisms in selection of donors for BMT.
Dorak MT; Chalmers EA; Sproul AM; Mills KI; Wilson DW; Galbraith I; Henderson N; Gibson BE; Burnett AK
Bone Marrow Transplant; 1993 Jan; 11(1):37-41. PubMed ID: 8094307
[TBL] [Abstract][Full Text] [Related]
14. Conservation of the central MHC genome: PFGE mapping and RFLP analysis of complement, HSP70, and TNF genes in the goat.
Cameron PU; Tabarias HA; Pulendran B; Robinson W; Dawkins RL
Immunogenetics; 1990; 31(4):253-64. PubMed ID: 1970334
[TBL] [Abstract][Full Text] [Related]
15. Haplospecific polymorphism between HLA B and tumor necrosis factor.
Wu X; Zhang WJ; Witt CS; Abraham LJ; Christiansen FT; Dawkins RL
Hum Immunol; 1992 Feb; 33(2):89-97. PubMed ID: 1563985
[TBL] [Abstract][Full Text] [Related]
16. Localization of the human MHC-linked complement genes between HLA-B and HLA-DR by using HLA mutant cell lines.
Whitehead AS; Colten HR; Chang CC; Demars R
J Immunol; 1985 Jan; 134(1):641-3. PubMed ID: 3917284
[TBL] [Abstract][Full Text] [Related]
17. Characterization of type I complement C2 deficiency MHC haplotypes. Strong conservation of the complotype/HLA-B-region and absence of disease association due to linked class II genes.
Truedsson L; Alper CA; Awdeh ZL; Johansen P; Sjöholm AG; Sturfelt G
J Immunol; 1993 Nov; 151(10):5856-63. PubMed ID: 7901282
[TBL] [Abstract][Full Text] [Related]
18. An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles.
Wilson AG; de Vries N; Pociot F; di Giovine FS; van der Putte LB; Duff GW
J Exp Med; 1993 Feb; 177(2):557-60. PubMed ID: 8426126
[TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of HLA class I and class II antigen loss mutants reveals a homozygous deletion of the DR, DQ, and part of the DP region: implications for class II gene order.
Erlich H; Lee JS; Petersen JW; Bugawan T; DeMars R
Hum Immunol; 1986 Jun; 16(2):205-19. PubMed ID: 3459724
[TBL] [Abstract][Full Text] [Related]
20. Polymorphism at expressed DQ and DR loci in five common equine MHC haplotypes.
Miller D; Tallmadge RL; Binns M; Zhu B; Mohamoud YA; Ahmed A; Brooks SA; Antczak DF
Immunogenetics; 2017 Mar; 69(3):145-156. PubMed ID: 27889800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
